Browse By Person: Sharpe, Jenny-Kay
|Up a level|
Group by: Item Type | Date
Number of items: 8.
Sharpe, Jenny-Kay, Stedman, T. J., Byrne, Nuala, & Hills, Andrew (2009) Low-fat oxidation may be a factor in obesity among men with schizophrenia. Acta Psychiatrica Scandinavica, 119(6), pp. 451-456.
Sharpe, Jenny-Kay, Byrne, Nuala M., Stedman, Terry J., & Hills, Andrew P. (2008) Comparison of clinical body composition methods in people taking weight-inducing atypical antipsychotic medications. Asia Pacific Journal of Clinical Nutrition, 17(4), pp. 573-580.
Sharpe, Jenny-Kay, Byrne, Nuala M., Stedman, Terry J., & Hills, Andrew P. (2008) Bioelectric impedance is a better indicator of obesity in men with schizophrenia than body mass index. Psychiatry Research, 159(1-2), pp. 121-126.
Sharpe, Jenny-Kay, Stedman, Terry J., Byrne, Nuala M., Wishart, Connie, & Hills, Andrew P. (2006) Energy expenditure and physical activity in clozapine use: implications for weight management. Australian & New Zealand Journal of Psychiatry, 40(9), pp. 810-814.
Sharpe, Jenny-Kay, Stedman, Terry J., Byrne, Nuala M., & Hills, Andrew P. (2006) Accelerometry is a valid measure of physical inactivity but not of energy expended on physical activity in people with schizophrenia. Schizophrenia Research, 85(1-3), pp. 300-301.
Byrne, Nuala, Hills, Andrew, Sharpe, Jenny-Kay, & Stedman, Terry (2005) Resting Energy Expenditure Is Lower than Predicted in People Taking Atypical Antipsychotic Medication. Journal of the American Dietetic Association, 105(4), pp. 612-615.
Hills, Andrew & Sharpe, Jenny-Kay (2003) Atypical Antipsychotic Weight Gain: A Major Clinical Challenge. Australian and New Zealand Journal of Psychiatry, 37(6), pp. 705-709.
Sharpe, Jenny-Kay (2007) Body composition and energy expenditure in men with schizophrenia. PhD thesis, Queensland University of Technology.